Nagendran Sukumar bought TSHA
November 28, 2025 · Form 4 insider transaction
Nagendran Sukumar bought 39,953 shares of Taysha Gene Therapies, Inc. at $1.71 per share, a transaction worth $68.3K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
39,953
Price
$1.71
Total value
$68.3K
InsiderNagendran Sukumar
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 28, 2025
Filing dateDecember 1, 2025
Shares owned after1,116,564
OwnershipDirect
10b5-1 planNo
AmendedNo